
A new Long Covid project makes information about clinical trials more accessible to people who may want to participate in research while showing gaps in the current search for meaningful treatments. Patient-researcher Ezra Spier developed the new project, called Long Covid Studies. As of its launch on March 26, the site includes details of about…

Downward Covid-19 trends continue across the major national data sources, as the U.S. keeps inching toward a lower-risk spring and summer. Flu and other respiratory viruses are trending down, too, though there are still a lot of pathogens going around.

Most national Covid-19 metrics point to continued slow declines in disease spread across the U.S. While the country is inching toward a lower-risk spring, levels of SARS-CoV-2 and other common viruses are still high in some places, particularly in the South and Midwest.

Continuing the tentatively good news from last week, all major Covid-19 metrics are trending toward declining disease spread. But there’s still a lot of this virus going around; it will be several more weeks before SARS-CoV-2 levels may actually be called low, especially in South and Midwest states that had late-winter peaks.

After a February of plateaus in Covid-19 spread, all major metrics are now pointing once again to a decline in transmission. A lower-risk spring is on the horizon in the coming weeks. Right now, though, viral levels remain high across the U.S., and the CDC’s recent change to its isolation guidance won’t help.

Last month, Dr. Ian Simon became the inaugural director of the U.S. Office of Long Covid Research and Practice, an office under the Department of Health and Human Services that aims to coordinate Long Covid efforts across the federal government. Betsy Ladyzhets spoke to Dr. Simon about his prior experience, his work at the Long…

The U.S.’s winter Covid-19 surge continues to drag on, with wastewater surveillance reporting high levels even as we head into March and relatively slow declines in hospitalizations. While this surge will surely lead to Long Covid, this result will be tough to track thanks to the abandonment of testing and relatively limited tracking efforts from health…

PolyBio Research Foundation, a leading organization in supporting research for Long Covid and related chronic diseases, announced a new round of funding focused on identifying potential Long Covid treatments on Thursday. The research projects, which received a total of $15 million in funding, plan to study the potential biological underpinnings of Long Covid and begin…

Last month, a U.S. government initiative launched a pair of surveys to collect information about how people with Long Covid are managing their symptoms. Data from these surveys, one for people with Long Covid and one for their doctors, will inform priorities for clinical trials.

Four months into the winter disease season, there’s still a lot of SARS-CoV-2 and other viruses going around. Wastewater and other indicators show that Covid-19 levels are still high across the country, not sharply declining as we usually expect for this time of year. Disease levels are particularly high in the South and Midwest.
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance